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Abstract
Background: To identify the genetic defect associated with autosomal recessive congenital cataract (ARCC),
mental retardation (MR) and ARCC, MR and microcephaly present in most patients in four Tunisian consanguineous
families.
Methods: We screened four genes implicated in congenital cataract by direct sequencing in two groups of
patients; those affected by ARCC associated to MR and those who presented also microcephaly. Among its three
genes PAX6, PITX3 and HSF4 are expressed in human brain and one gene LIM2 encodes for the protein MP20 that
interact with the protein galectin-3 expressed in human brain and plays a crucial role in its development. All genes
were screened by direct sequencing in two groups of patients; those affected by ARCC associated to MR and
those who presented also microcephaly.
Results: We report no mutation in the four genes of congenital cataract and its flanking regions. Only variations
that did not segregate with the studied phenotypes (ARCC associated to MR, ARCC associated with MR and
microcephaly) are reported. We detected three intronic variations in PAX6 gene: IVS4 -274insG (intron 4), IVS12
-174G>A (intron12) in the four studied families and IVS4 -195G>A (intron 4) in two families. Two substitutions
polymorphisms in PITX3 gene: c.439 C>T (exon 3) and c.930 C>A (exon4) in one family. One intronic variation in
HSF4 gene: IVS7 +93C>T (intron 7) identified in one family. And three intronic substitutions in LIM2 gene identified
in all four studied families: IVS2 -24A>G (intron 2), IVS4 +32C>T (intron 4) and c.*15A>C (3’-downstream sequence).
Conclusion: Although the role of the four studied genes: PAX6, PITX3, HSF4 and LIM2 in both ocular and central
nervous system development, we report the absence of mutations in all studied genes in four families with
phenotypes associating cataract, MR and microcephaly.
Background
Congenital cataracts show considerable clinical and
locus heterogeneity and represent one of the major
causes of vision loss world-wide [1]. Cataracts can be
isolated or can occur in association with a large number
of different metabolic diseases or genetic syndromes [2].
Non syndromic congenital cataract has an estimated fre-
quency of 1-6 per 100,000 live births [3].
More than 20 genes have been implicated in human
congenital cataract, most of them are responsible for the
autosomal dominant trait than the autosomal recessive
one [4,5] in these can be divided into two clusters
according to the stage of lens development at which
they are involved. The first group contains genes that
determine lens structure and genes related to structure,
including crystallins, Bfsp, connexions and MIP [4-6].
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LIM2 gene (lens intrinsic membrane protein-2) involved
in autosomal recessive congenital cataract [7,8]. It
encodes an abundant integral lens membrane protein
MP20 which is a new regulatory protein important for
mammalian lens fiber cell junctional formation [9].
Lens-specific MP20 is classified as a member of the
PMP22/EMP/MP20 subfamily of tetraspanins [10] and
adds to a growing list of ligands of galectin-3[11], a
known adhesion modulator that is expressed by micro-
glial cells of adult brain [12] and contributes to injury in
the deep gray matter areas of the brain [13].
The second group of genes including transcription
factors PAX6, PITX3 and HSF4 member of the heat
shock transcription factor (HSF) family [6]. These three
transcription factors are expressed in the human brain
and led to autosomal dominant or autosomal recessive
congenital cataract or both.
PAX6 gene (Paired box homeotic gene 6), 11p13, a
paired box transcription factor, was described the
among the wide set of genes responsible for autosomal
dominant congenital cataract (ADCC) [14] that is
expressed in the developing eye, brain, spinal cord and
pancreas and seems to play a crucial role in the develop-
ing of the central nervous system by transcriptional reg-
ulation of various target genes [15,16].
PITX3 gene (Pituitary homeobox gene 3) mapped on
10q24.32, is also responsible for ADCC and expressed in
the developing lens, skeletal muscle, and dopaminergic
neurons of the substantia nigra in the brain [17].
HSF4 gene (Heat-shock transcription factor 4) localized
on 16q21-q22.1 and for which mutations are associated
with both autosomal dominant [18] and autosomal reces-
sive congenital cataract (ARCC) [19-21]. In the human,
HSF4 is widely expressed, especially in the heart, brain,
skeletal muscle, lung and pancreas [22,23].
Based on these observations, we analysed the four
genes: LIM2, PAX6, PITX3 and HSF4 in four consangui-
neous unrelated Tunisian families with ARCC associated
with mental retardation (MR) for two patients belonging
to the same family and ARCC associated to MR and
microcephaly for the others from the four studied
families.
Methods
Subjects and sample collection
We evaluated seventeen patients (7 parents, 10 patients
including 9 affected and 1 normal from family F1)
belonging to four Tunisian unrelated families (Figure 1)
recruited from Congenital and Hereditary Disorders
Department at Charles-Nicolle Hospital (Tunis,
Tunisia).
All four families were of Tunisian origin and were
enrolled in a genetic research program in the laboratory
of Human Genetics, in the faculty of medicine (Tunis,
Tunisia) because of two affected brothers belonging to
family F2 with ARCC and MR and seven affected
patients from the four studied families (F1, F2, F3, F4)
with ARCC, MR and microcephaly.
The nine patients (5 males, 4 females) were born from
healthy and consanguineous parents. Pedigrees’ patterns
are concordant with autosomal recessive inheritance for
the four families (Figure 1). Their mean age was 23
years, ranging from 8 to 41 years. We noted that the
father from family F1 was dead after au traumatic acci-
dent. Cataracts were reportedly present since birth in all
patients. None had glaucoma before or after the extrac-
tion of cataracts.
The cataracts were of the posterior polar type and
bilateral in all patients except of the affected child IV11
belonging to family F4. All patients had undergone cat-
aract extraction early in life. Visual acuity was preserved
in all patients except of the affected child IV12 from
family F4 who showed decreased visual acuity and
alteration of the pigment epithelium. We denoted the
presence of retinal dystrophy and strabismus in patient
IV16 belonging to family F1. We underlined also the
presence of nystagmus, microphthalmia and strabismus
in patient IV11 from family F3 whose brother IV10 pre-
sented also microphthalmia.
Significant physical disability became apparent for all
patients by the age of 15 to 18 months when they failed
to walk. They also had a significant delay in speech
development. In fact, the nine affected patients were
developmentally delayed with mild to moderate mental
retardation with no dysmorphic features. Microcephaly
Figure 1 Pedigrees of the four studied families. Filled squares
with oblique lines pointing to the right describe patients with
Congenital cataract, Mental retardation and Microcephaly, filled
squares with horizontal lines represent patients with Congenital
cataract and Mental retardation, filled squares with vertical lines
describe patients with Mental retardation and filled circles represent
patient with Late-onset cataract. The asterisk indicates not examined
patients.
Chograni et al. BMC Ophthalmology 2011, 11:35
http://www.biomedcentral.com/1471-2415/11/35
Page 2 of 8was present in all of them except the two brothers IV36
and IV37 belonging to family F2. Additional features are
shown in table 1.
Magnetic resonance imaging (MRI) of the brain was
normal in all screened patients except for the presence
of a small ischemic parietal lesion in patient IV16 from
family F1 and the presence of Dandy-Walker anomaly
with thinning of corpus callosum in patients IV10 and
IV11, belonging to family F3, whose sister IV9 showing
MR, bilateral congenital cataract, microcephaly and epi-
lepsy was dead at 3 years.
Biological investigations (karyotyping with R-banding)
revealed normal karyotypes; 46,XX for females, 46,XY for
males (600 bands resolution) and normal metabolic
screening including Fehling reaction and thin layer chro-
matography of reducing sugars, plasmatic amino acid
and urine organic acid chromatography for all patients.
Genomic DNA of affected and unaffected members
(10 siblings, 7 parents) was extracted from peripheral
blood leukocytes by the standard proteinase-K
extraction consisting on: lysis of red blood cells by RBC
(Red Blood Cells) Lysis Buffer (155 mM NH4Cl, 10 mM
KHCO3, 0.5 EDTA, pH 7.5) and white blood cells by a
WBC (White Blood Cells) Lysis Buffer (1 mM Na-
EDTA, 5 mM Tris HCl pH 7.5), treatment of the lysate
with a mixture of detergent composed of SDS (Sodium
Dodecyl Sulfate or sacrosyl and proteinase K) in order
to liberate the DNA and digest the associated proteins,
precipitation of the DNA in the form of filaments by
absolute ethanol and finally diluation of the DNA in
T10E1 Buffer (Tris 10 mM, EDTA 0.1-1 mM), and
stored in 10 ml Vacuum tube sterile containing 100 μl
of 0.1 M EDTA.K3.
Patients and parents for minors gave informed
consent
In this study, the researches carried out on human are
in compliance with the Helsinki Declaration and ethics
committee Charles Nicolle hospital, Tunis has given
approval for this study.
Table 1 Clinical features of the 9 affected patients belonging to the four studied families: F1, F2, F3 and F4
Familles F1 F2 F3 F4
Patients IV13 IV16 IV35 IV36 IV37 IV10 IV11 IV11 IV12
Weigt (Kg) N N N N N NNNN
Height (cm) N N N N N NNNN
Cataract unilateral bilateral bilateral bilateral bilateral bilateral bilateral unilateral bilateral
Age of
cataract
3 years 3 years 2 years 3 years 2 years 6 months 1 year 3 years 3 years
Microcephaly -5.5 DS -6.7 DS -2.8 DS N N -3.5 DS -3 DS -5.6 DS -3.8 DS
MR moderate moderate moderate moderate mild moderate moderate moderate moderate
Age of MR 3 years 3 years 2 years 3 years 2 years 1 year 3 years 3 years 3 years
Developmental
delay
-Could not learn nor write.
-Troubles of eloculation
-Running all alone.
-Walked at age of 2
years.
-Difficult to shake
hands and close
eyes.
-Walked at
2 years.
-Spoke at 5
years.
-Absence
of
anatomy.
Difficult
to learn.
-Spoke at 2 years.
-Speech with
monosyllabic words.
Walked and spoke at ages of 2
years.
IV10 -Sit with
supports since 5
months.
IV 10 -Walk with
assistance gained.
MRI N Small parietal
ischemic lesion
N N N -Anomaly if Dandy-
Walker.
-Thinning of corpus
callosum.
NN
Others Slight axial
hypotonia
-Retinal
dystrophy
-Strabismus
- . - - -Microphtalmia.
-Axial hypotonia.
-Intrauterine growth
retardation.
IV10- Bilateral
cryptorchidism
operated.
- -Alteration of the
pigment
epithelium.
-Leucorea
-Decreased visual
acuity.
MR: Mental Retardation, MRI: Magnetic Resonance Image, N: normal, -: no other features
Age of MR = age of the patient at the first time referred to our department.
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All exons and intron-exon junctions of the four genes:
LIM2 (4 exons), PAX6 (14 exons), PITX3 (4exons),
HSF4 (13 exons) were amplified from genomic DNA by
polymerase chain reaction (PCR) using primers chosen
by Primer3 (Primer3-web/hldocs/inpat-040.htm).
The genes sequences were retrieved from the Ensembl
database; (ENST00000221973 for LIM2/ENST00000
419022 for PAX6/ENST00000370002 for PITX3 and
ENST00000264009 for HSF4).
The amplification reactions were performed by using
100 ng of each patients’ genomic DNA as a template, 20
pmol of each primer (Biomatik, Canada), a MgCl2 con-
centration depending upon the exon amplified, 1.5 Units
of Taq DNA polymerase recombinant (Invitrogen, Carls-
bad), and 1.25 mM dNTP (Promega, Madison) in a total
volume of 50 μl. PCR consisted on 35 cycles and was
carried out in an automated thermal cycle GeneAmp
PCR System 9700 (Applied Biosystems, Foster city)
under the following conditions: 95°C for 5 min, 95°C for
30 s, then 52-60°C for 30 s, and elongation at 72°C for
30 s, followed by one cycle of extension at 72°C for 7
min.
The amplified products were purified (Wizard
® SV
G e la n dP C RC l e a n - U pS y s t e mK i t ;P r o m e g a )a n d
sequenced (Big Dye Terminator Cycle Sequencing
Ready Reaction; DNA Sequencing Kit; ABI PRISM
3130) in the forward and reverse directions. Sequencing
results were visualized and data were computer analyzed
using Sequencing Analysis 5.2 and SeqScape softwares
(Applied Biosystems, Foster City).
Results
Screening of nine affected siblings from four Tunisian
families for LIM2, PAX6, PITX3 and HSF4 pathogenic
mutations revealed no mutation in the corresponding
exons of each gene.
For LIM2 gene (exon 1 is an UTR for non-translated
region), sequence analysis showed novel intronic
changes involving modifications: IVS2 -24A>G in intron
2; IVS4 +32C>T in intron 4; c.*15A>C in 3’ down-
stream sequence. All affected and unaffected individuals
were homozygous for the modified alleles.
The same for PAX6 gene, in that we detected novel
intronic variations entailing: IVS4 -274insG in intron 4,
IVS12 -174G>A in intron 11, identified in all four
families and IVS4 -195G>A in intron 4 identified only
in families F3 and F4 (we considered the isoform PAX6
(+5a) for mutation nomenclature).
For PITX3 gene, we identified two substitutions poly-
morphisms in family F1: an already reported silent poly-
morphism, c.439C>T single nucleotide polymorphism
(SNP rs2281983), in exon 3 that conserved the same
amino acid Isoleucine (I) in the protein sequence p.
I95I. Another unreported variation c.930C>A in exon 4,
resulting in a proline to leucine substitution at position
258 of the protein. These two exonic changes are not
included in a conserved domain of PITX3 (we consid-
ered the first nucleotide of the cDNA sequence nucleo-
tide number one).
And for HSF4 gene, we revealed one novel intronic
variation; IVS7 +93C>T in intron 7 detected only in
family F1.
The variations identified in these four screened genes
did not segregate with the phenotypes (ARCC, MR and
ARCC, MR and microcephaly) because of the absence of
correlation between genotypes (homozygous/heterozy-
gous) and autosomal recessive inheritance of such stu-
died phenotypes in the four pedigrees (Table 2).
For each novel variation identified in the four studied
genes, 50 normal unrelated controls were screened and
results are indicated in table 3.
Concerning LIM2 and PAX6 genes, control samples
were either heterozygous or homozygous for the variable
alleles which confirmed the fact that these variations did
not segregate with the studied phenotype in the four
families.
But for PITX3 and HSF4 genes although variations
were absent in 50 ethnically matched control samples,
there is no segregation between these detected poly-
morphisms and the studied phenotype (association
between congenital cataract, mental retardation and
microcephaly) in family F1.
Discussion
Congenital cataracts are common major abnormalities
of the eye, which frequently cause blindness in infants
[24]. It may occur as an isolated anomaly, as part of
generalized ocular development defects, or as a compo-
nent of a multisystem disorder [24]. In fact, association
of cataract with congenital anomalies, mental retarda-
tion and microcephaly is reported in several cases with
chromosomal anomalies and syndromes from genic ori-
gins [25-27].
Until today no candidate gene has been reported
responsible for such phenotypes: association between
congenital cataract, MR and congenital cataract, MR
and microcephaly, so we tried to focus on genes already
d e s c r i b e di nA D C Ca n d / o rA R C Ca n de x p r e s s e di nt h e
human brain (PAX6, PITX3 and HSF4). And we chose
to investigate the role of LIM2 gene in such phenotypes
regarding the interaction between the proteins MP20
and galectin-3 in lens fiber cell.
MP20, a member of the tetraspanin superfamily, is the
most abundant integral membrane protein of lens fiber
cells, which appears to be distributed uniformly in the
plasma membrane but also occurs in distinct membrane
junctional domains early during embryonal development
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crystalline fiber cell arrangement in the lens and cause
cataractogenesis [7,8,31]. Tetraspanins form contacts
with other cells or the extracellular matrix by binding to
other tetraspanins, to adhesion receptors such as integ-
rins, and to extracellular proteins [32-34]; in this con-
text, recently MP20 and galectin-3 were identified to co-
localize in selected areas of the cell plasma membrane
and biochemical analysis confirmed that MP20 and
galectin-3 interact with each other [11]. In fact, galectin-
3 is a multifunctional protein, which occurs early during
embryonal development, with reported involvement in
development, oncogenesis, and inflammation [35]. It
was found to be expressed by microglial cells [12],
detected in a number of astrocytes in adult rat brain
[36] and leads to injury in the deep gray matter areas of
the brain [13]. In addition, LIM2 has been implicated in
autosomal recessive cataract and reported for the first
time on 2002 by Pras and co-workers [7]. By sequencing
of LIM2, they revealed a Phe105Val mutation leading to
a phenotype with a late-onset of cataract characterised
by nuclear opacities, mild to moderate visual loss in
three affected sibs whose healthy brother showed mental
retardation with clear lens. On 2008, a second mutation
Gly154Glu was reported by Ponnam and co-workers [8]
in a phenotype involving congenital cataracts with
severe visual impairment indicated by the presence of
nystagmus and amblyopia but also with no sign of MR.
For PAX6 gene, it was first described as a candidate
for human aniridia and ADCC but not for ARCC [37].
PAX6 expression is not restricted to the eye and appears
to be crucial for brain development [38]. In order to
elucidate this hypothesis, Dansault et al. [39] reported
14 affected members carrying a p.S74G mutation in
Table 2 Polymorphic changes identified in PAX6, PITX3 and HSF4 genes in the studied patients from the four Tunisian
families (F1, F2, F3, and F4)
Familles Patients PAX6 intronic variations PITX3 subtitution polymorphisms HSF4 intronic variation
IVS4 -274insG IVS12 -174G>A IVS4 -195G>A c.439 C>T (exon 3) c.930 C>A (exon 4) IVS7 +93C>T
F1 III9 homozygous heterozygous wild type heterozygous heterozygous heterozygous
IV13 homozygous homozygous wild type heterozygous heterozygous heterozygous
IV14 homozygous homozygous wild type wild type heterozygous wild type
IV16 homozygous homozygous wild type wild type heterozygous wild type
F2 III19 homozygous heterozygous wild type wild type wild type wild type
III20 homozygous homozygous wild type wild type wild type wild type
IV35 homozygous homozygous wild type wild type wild type wild type
IV36 homozygous homozygous wild type wild type wild type wild type
IV37 homozygous homozygous wild type wild type wild type wild type
F3 III9 homozygous heterozygous heterozygous wild type wild type wild type
III10 homozygous heterozygous heterozygous wild type wild type wild type
IV11 homozygous heterozygous wild type wild type wild type wild type
IV12 homozygous heterozygous heterozygous wild type wild type wild type
F4 III7 homozygous heterozygous heterozygous wild type wild type wild type
III8 homozygous heterozygous heterozygous wild type wild type wild type
IV10 homozygous wild type homozygous wild type wild type wild type
IV11 homozygous heterozygous heterozygous wild type wild type wild type
Table 3 Frequency of the novel SNPs, identified in the four screened genes, on 50 normal controls
Gene/Variation Homozygous (for the variation) Heterozygous (for the variation) Wild type
IVS2 -24A>G 11 (22%) 0 39 (78%)
LIM2 IVS4 +32C>T 39 (78%) 11 (22%) 0
c.*15A>C 35 (70%) 15 (30%) 0
IVS4 -274insG 46 (92%) 4 (8%) 0
PAX6 IVS12 -174G>A 0 9 (18%) 41 (82%)
IVS4 -195G>A 11 (22%) 25 (50%) 14 (28%)
PITX3 c.930C>A (exon 4) 0 0 50 (100%)
HSF4 IVS7 +93C>T 0 0 50 (100%)
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diverse congenital ocular abnormalities including conge-
nital cataracts, diverse neurological manifestations and
variable cognitive impairments. Recently, Chien et al.
[40] had identified a p.R317X PAX6 mutation in a
patient (familial case) suffering from cataract, aniridia,
nystagmus and was developmentally delayed. So these
two reports proved that the PAX6 gene has a key role as
a master regulator in the development of the eye and
central nervous system.
As for PITX3, it was demonstrated to cause cataract
and anterior segment mesenchymal dysgenesis (ASMD)
in several families from different ethnic origins [41,42].
It has been described only in ADCC but not in ARCC
[43]. Recently, Bidinost and coworkers (2006) reported
one large Lebanese family where patients with a hetero-
zygous mutation in PITX3 (650delG) had posterior polar
cataracts (PPCs), while patients with the same mutation
but with the homozygous state had a more severe ocular
effect with severe microphthalmia associated with devel-
opmental delay and mental retardation. In addition, the
two homozygous brothers are offspring of a consangui-
neous marriage, and their parents, who presented with
PPCs, were examined through the 28 affected members
and were heterozygous for the reported deletion. The
neurologic phenotype of the homozygous patients
implies an essential role for PITX3 in normal ocular and
central nervous system development and this was the
first report in which a potential new role of PITX3 in
the development of the nervous system has been proved.
The last studied gene is HSF4 which was identified
sufficiently important to lens development [44,45] and
disruption of the HSF4 gene leads to both autosomal
dominant and ARCC (11-13). Bu et al. [18] reported, on
2002, four different missense mutations, within the
HSF4 DNA binding domain, in patients with autosomal
dominant lamellar and Marner cataracts from a large
Chinese family. On 2004, Smaoui et al. [19] reported for
the first time a HSF4 homozygous splice mutation in
intron 12 (c.1327+4A>G) causing the skipping of exon
12 and leading to the installation of ARCC in a consan-
guineous Tunisian family. Then, Sajjad and coworkers
[20] identified a novel HSF4 gene mutation (p.R405X)
causing ARCC in a large consanguineous family from
Pakistan. In the human, HSF4 is widely expressed, espe-
cially in the brain, heart, skeletal muscle, lung and pan-
creas [22,23].
Taking these results further, we analysed LIM2, PAX6,
PITX3 and HSF4 genes in four consanguineous Tunisian
families with nine affected patients showing ARCC, MR
for two brothers from F2 and ARCC, MR and microce-
phaly for the seven other patients belonging to the four
families, but we did not identify any pathogenic mutation.
Only novel intronic variations; IVS2 -24A>G, IVS4
+32C>T, c.*15A>C detected in LIM2 gene, IVS4
-274insG, IVS12 -174G>A, IVS4 -195G>A identified in
PAX6 gene and IVS7 +93C>T in HSF4 gene. And sub-
stitution polymorphisms; a reported one c.439 C>T
(rs2281983) and a novel SNP c.930 C>A revealed
respectively in exons 3 and 4 of PITX3 gene. These
modifications did not segregate with studied phenotypes
(ARCC, MR and ARCC, MR and microcephaly).
T h e s ef i n d i n g sd i dn o te x c l u d et h er o l eo fLIM2,
PAX6, PITX3 and HSF4 gene in both ocular and central
nervous system but it underlined the fact that these
transcription factors (PAX6, PITX3), heat-shock tran-
scription factor (HSF4) and lens intrinsic membrane
protein (LIM2) could not be responsible for the associa-
tion between ARCC, MR and ARCC, MR and microce-
phaly in the four studied Tunisian families in spite of
t h e i re x p r e s s i o ni nt h eh u m a nb r a i n( PAX6, PITX3,
HSF4) or their interaction with proteins expressed in
human brain (LIM2).
Conclusion
In conclusion, a genome wide scan must be performed
for these four families in order to identify candidate
regions so that candidate gene(s) leading to such
association.
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We use ARCC for autosomal recessive congenital cataract, MR for mental
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homeobox gene 3, HSF4 for Heat-shock transcription factor 4, LIM2 for lens
intrinsic membrane protein-2 and ADCC for autosomal dominant congenital
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